Vectura wins patent litigation battle against GSK, awarded $89.7M PharmaTimes
Vectura has confirmed that it has won the US GlaxoSmithKline (GSK) patent litigation trial and has been awarded $89.7million in damages by the trial jury.
Vectura wins patent litigation battle against GSK, awarded $89.7M PharmaTimes
Vectura has confirmed that it has won the US GlaxoSmithKline (GSK) patent litigation trial and has been awarded $89.7million in damages by the trial jury.